Oncomine Comprehensive Panel with Tumor Mutation Burden, MSI, and PDL1 Testing
Comprehensive Cancer Genomic Analysis for Personalized Treatment
The Oncomine Comprehensive Panel represents a revolutionary approach to cancer diagnostics, combining multiple advanced genomic technologies to provide a complete picture of your tumor’s genetic landscape. This sophisticated testing platform integrates next-generation sequencing (NGS), Sanger sequencing, and immunohistochemistry (IHC) methodologies to deliver comprehensive insights that guide precision oncology decisions.
What This Advanced Test Measures and Detects
Our comprehensive panel evaluates multiple critical biomarkers simultaneously:
- Tumor Mutation Burden (TMB): Quantifies the total number of mutations within tumor DNA, serving as a predictive biomarker for immunotherapy response
- Microsatellite Instability (MSI): Assesses DNA mismatch repair deficiency, indicating potential for Lynch syndrome and eligibility for specific immunotherapies
- PDL1 Expression: Measures programmed death-ligand 1 protein levels, a key biomarker for immune checkpoint inhibitor therapies
- Comprehensive Gene Panel: Analyzes over 500 cancer-related genes for mutations, amplifications, fusions, and copy number variations
Who Should Consider This Comprehensive Cancer Testing
This advanced genomic panel is particularly beneficial for:
- Patients with advanced or metastatic cancers seeking targeted therapy options
- Individuals with treatment-resistant malignancies requiring alternative therapeutic strategies
- Patients being considered for immunotherapy to determine potential response
- Those with family histories of cancer or suspected hereditary cancer syndromes
- Individuals with rare or difficult-to-classify tumors requiring comprehensive genomic profiling
- Patients seeking second opinions or additional treatment options after standard therapies
Key Benefits of Comprehensive Cancer Genomic Testing
- Personalized Treatment Planning: Identifies specific genetic alterations that can be targeted with precision medicines
- Immunotherapy Guidance: Determines eligibility and potential response to immune checkpoint inhibitors
- Clinical Trial Matching: Identifies potential eligibility for cutting-edge clinical trials based on genetic markers
- Prognostic Information: Provides insights into disease progression and potential treatment outcomes
- Comprehensive Analysis: Single test replaces multiple individual biomarker tests, saving time and tissue samples
Understanding Your Test Results
Your comprehensive report will include detailed information about:
- TMB Classification: High, intermediate, or low tumor mutation burden with clinical implications
- MSI Status: Microsatellite stable (MSS) or unstable (MSI-H) with therapeutic recommendations
- PDL1 Expression Levels: Quantitative assessment with interpretation guidelines
- Actionable Mutations: Specific genetic alterations with FDA-approved targeted therapies
- Clinical Trial Opportunities: Potential matches for ongoing research studies
- Hereditary Cancer Risk: Identification of germline mutations that may indicate inherited cancer predisposition
Test Pricing and Sample Requirements
| Test Component | Regular Price | Discount Price |
|---|---|---|
| Oncomine Comprehensive Panel with TMB, MSI, PDL1 | $4000 USD | $3000 USD |
Sample Requirements:
- Tumor tissue (paraffin-embedded blocks)
- Peripheral blood sample (EDTA Vacutainer, 3 ml)
- Turnaround time: 2-3 weeks
Pre-Test Instructions and Requirements
The Oncomine Comprehensive Panel requires a physician’s prescription for testing. Please note that prescription requirements do not apply to surgical cases, pregnancy-related testing, or individuals planning international travel. Our genetic counselors are available to discuss testing indications and help coordinate sample collection.
Nationwide Testing Availability
We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures accessible, high-quality cancer genomic testing for patients nationwide.
Take the Next Step in Your Cancer Journey
Don’t leave your treatment decisions to chance. Comprehensive genomic profiling can reveal critical information about your cancer that may open doors to targeted therapies and immunotherapies. Our team of oncology specialists and genetic counselors is ready to help you understand your options and navigate the testing process.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your comprehensive cancer genomic testing or to speak with one of our genetic specialists about whether this advanced testing is right for your situation.
Take control of your cancer treatment with the most advanced genomic analysis available. Book your Oncomine Comprehensive Panel today and discover the power of precision oncology.
